A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -38.67% this year. Over the last six months, there has been a stronger performance of -57.27%. The price of ALGS leaped by -29.70% during the last 30 days period. For the last 5-days stocks have slided -27.44%.
The stock market performance of Aligos Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $30.00 on 03/04/24, while the lowest price during the same time frame was $8.70, recorded on 06/28/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ALGS Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Aligos Therapeutics Inc’s current trading price is -66.07% away from its 52-week high, while its distance from the 52-week low is 16.94%. The stock’s price range over this timeframe has been between $8.70 and $30.00. The shares of the Healthcare sector company recorded a trading volume of approximately 0.87 million for the day, which was comparatively higher than the average daily volume of 39240.0 over the last three months.
The Connection Between Financial Performance and Market Capitalization
Aligos Therapeutics Inc (ALGS) has experienced a quarterly decline of -2.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.58M and boasts a workforce of 66 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.88, with a change in price of -9.37. Similarly, Aligos Therapeutics Inc recorded 36,797 in trading volume during the last 100 days, posting a change of -47.93%.
ALGS’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ALGS stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.10.
ALGS Stock Stochastic Average
Aligos Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 2.92%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 2.92%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 26.46% and 35.01%, respectively.
